Acadia Healthcar Financials
This page shows Acadia Healthcar (ACHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Heavy reinvestment and a likely non-cash asset reset are dominating results more than day-to-day core cash generation.
FY2025's-$1.10B net loss did not coincide with a cash collapse: operating cash flow stayed positive at$132M , while goodwill fell by roughly$969M from FY2024. That combination points to earnings being hit mainly by balance-sheet write-downs and reinvestment demands rather than the underlying business suddenly consuming cash at the same scale.
The business has become far more capital-intensive: capital spending was
Liquidity improved in FY2025, with the current ratio recovering to 1.6x from 1.0x, but the balance sheet also carried more financial leverage: long-term debt climbed to
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Acadia Healthcar's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Acadia Healthcar's revenue grew 5.0% year-over-year to $3.3B, a solid pace of expansion. This earns a growth score of 44/100.
Acadia Healthcar carries a low D/E ratio of 1.27, meaning only $1.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 76/100, indicating a strong balance sheet with room for future borrowing.
Acadia Healthcar's current ratio of 1.55 is below the typical benchmark, resulting in a score of 27/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While Acadia Healthcar generated $131.9M in operating cash flow, capex of $571.8M consumed most of it, leaving -$439.9M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Acadia Healthcar generates a -56.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 8.3% the prior year.
Acadia Healthcar passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Acadia Healthcar generates $-0.12 in operating cash flow ($131.9M OCF vs -$1.1B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Acadia Healthcar generated $3.3B in revenue in fiscal year 2025. This represents an increase of 5.0% from the prior year.
Acadia Healthcar reported -$1.1B in net income in fiscal year 2025. This represents a decrease of 531.4% from the prior year.
Acadia Healthcar earned $-12.16 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 537.4% from the prior year.
Cash & Balance Sheet
Acadia Healthcar generated -$439.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 21.5% from the prior year.
Acadia Healthcar held $133.2M in cash against $2.5B in long-term debt as of fiscal year 2025.
Acadia Healthcar had 90M shares outstanding in fiscal year 2025. This represents a decrease of 1.4% from the prior year.
Margins & Returns
Acadia Healthcar's net profit margin was -33.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 41.4 percentage points from the prior year.
Acadia Healthcar's ROE was -56.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 64.9 percentage points from the prior year.
Capital Allocation
Acadia Healthcar spent $50.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Acadia Healthcar invested $571.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.2% from the prior year.
ACHC Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $828.8M+0.9% | $821.5M-3.5% | $851.6M-2.0% | $869.2M+12.8% | $770.5M-0.5% | $774.2M-5.1% | $815.6M+2.5% | $796.0M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $467.0M+139.5% | -$1.2B-355.8% | $462.2M+2.2% | $452.4M+1.6% | $445.3M+140.2% | -$1.1B-358.9% | $428.1M+2.0% | $419.8M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | -$38.3M-1.1% | -$37.9M-3.6% | -$36.6M-4.2% | -$35.1M-20.4% | -$29.2M+3.0% | -$30.1M-0.5% | -$29.9M-2.6% | -$29.2M |
| Income Tax | $6.5M-17.1% | $7.8M+370.2% | $1.7M-86.2% | $12.1M+174.0% | $4.4M-1.7% | $4.5M-83.5% | $27.2M+6.1% | $25.6M |
| Net Income | $4.1M+100.3% | -$1.2B-3348.7% | $36.2M+20.3% | $30.1M+259.8% | $8.4M-74.3% | $32.6M-52.1% | $68.1M-13.2% | $78.5M |
| EPS (Diluted) | $0.05 | N/A | $0.40+21.2% | $0.33+266.7% | $0.09 | N/A | $0.74-12.9% | $0.85 |
ACHC Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.5B+0.3% | $5.5B-13.8% | $6.4B+1.7% | $6.3B+2.6% | $6.1B+3.2% | $6.0B+1.5% | $5.9B+3.4% | $5.7B |
| Current Assets | $837.2M+2.8% | $814.1M+8.8% | $748.0M+8.2% | $691.6M+8.2% | $639.0M+10.6% | $577.5M-11.4% | $652.1M+1.1% | $645.2M |
| Cash & Equivalents | $158.5M+18.9% | $133.2M+12.3% | $118.7M-9.7% | $131.4M+44.0% | $91.2M+19.6% | $76.3M-7.1% | $82.1M+6.5% | $77.2M |
| Inventory | $5.9M+4.3% | $5.7M-9.0% | $6.2M+7.4% | $5.8M+1.9% | $5.7M+1.0% | $5.7M+2.5% | $5.5M-7.9% | $6.0M |
| Accounts Receivable | $471.8M+7.1% | $440.6M+2.3% | $430.8M+5.5% | $408.5M+3.0% | $396.6M+8.6% | $365.3M-4.8% | $383.9M-1.4% | $389.4M |
| Goodwill | $1.3B+0.4% | $1.3B-43.3% | $2.3B+0.4% | $2.3B0.0% | $2.3B+0.5% | $2.3B0.0% | $2.3B+0.2% | $2.3B |
| Total Liabilities | $3.4B-0.3% | $3.4B+8.5% | $3.1B+1.2% | $3.1B+3.7% | $3.0B+7.5% | $2.8B+1.5% | $2.7B+4.2% | $2.6B |
| Current Liabilities | $489.4M-6.8% | $525.2M+1.4% | $517.9M-1.1% | $523.7M+10.6% | $473.4M-18.1% | $577.9M-5.2% | $609.5M+11.5% | $546.5M |
| Long-Term Debt | $2.5B+0.9% | $2.5B+8.2% | $2.3B+1.7% | $2.2B+2.9% | $2.2B+16.2% | $1.9B+4.2% | $1.8B+1.7% | $1.8B |
| Total Equity | $2.0B+0.5% | $1.9B-37.5% | $3.1B+1.4% | $3.1B+1.2% | $3.0B-1.0% | $3.1B+1.4% | $3.0B+2.7% | $3.0B |
| Retained Earnings | -$761.7M+0.5% | -$765.8M-286.0% | $411.7M+9.7% | $375.4M+7.7% | $348.5M-10.0% | $387.3M+9.2% | $354.7M+23.8% | $286.6M |
ACHC Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $61.5M+171.3% | -$86.3M-217.9% | $73.2M-45.2% | $133.5M+1063.2% | $11.5M-90.2% | $116.7M-28.5% | $163.1M-4.7% | $171.1M |
| Capital Expenditures | $76.6M-17.8% | $93.2M-31.6% | $136.2M-18.8% | $167.7M-3.9% | $174.6M-14.2% | $203.5M+7.0% | $190.2M+23.3% | $154.2M |
| Free Cash Flow | -$15.0M+91.6% | -$179.5M-184.8% | -$63.0M-84.1% | -$34.2M+79.0% | -$163.2M-88.0% | -$86.8M-220.2% | -$27.1M-260.4% | $16.9M |
| Investing Cash Flow | -$60.2M+34.9% | -$92.4M+28.8% | -$129.8M+13.9% | -$150.8M+17.7% | -$183.2M+9.9% | -$203.3M-5.3% | -$193.1M-24.2% | -$155.5M |
| Financing Cash Flow | $23.9M-87.6% | $193.3M+341.1% | $43.8M-23.7% | $57.5M-69.2% | $186.7M+131.1% | $80.8M+131.5% | $34.9M+320.9% | -$15.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | $0 | $0-100.0% | $3.2M-93.3% | $46.9M | N/A | N/A | N/A |
ACHC Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 0.5%+143.8pp | -143.3%-147.6pp | 4.3%+0.8pp | 3.5%+2.4pp | 1.1%-3.1pp | 4.2%-4.1pp | 8.3%-1.5pp | 9.9% |
| Return on Equity | 0.2%+60.6pp | -60.4%-61.6pp | 1.2%+0.2pp | 1.0%+0.7pp | 0.3%-0.8pp | 1.1%-1.2pp | 2.3%-0.4pp | 2.7% |
| Return on Assets | 0.1%+21.4pp | -21.3%-21.9pp | 0.6%+0.1pp | 0.5%+0.3pp | 0.1%-0.4pp | 0.5%-0.6pp | 1.2%-0.2pp | 1.4% |
| Current Ratio | 1.71+0.2 | 1.55+0.1 | 1.44+0.1 | 1.32-0.0 | 1.35+0.4 | 1.00-0.1 | 1.07-0.1 | 1.18 |
| Debt-to-Equity | 1.270.0 | 1.27+0.5 | 0.730.0 | 0.73+0.0 | 0.72+0.1 | 0.61+0.0 | 0.600.0 | 0.60 |
| FCF Margin | -1.8%+20.0pp | -21.9%-14.5pp | -7.4%-3.5pp | -3.9%+17.2pp | -21.2%-10.0pp | -11.2%-7.9pp | -3.3%-5.4pp | 2.1% |
Similar Companies
Frequently Asked Questions
What is Acadia Healthcar's annual revenue?
Acadia Healthcar (ACHC) reported $3.3B in total revenue for fiscal year 2025. This represents a 5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Acadia Healthcar's revenue growing?
Acadia Healthcar (ACHC) revenue grew by 5% year-over-year, from $3.2B to $3.3B in fiscal year 2025.
Is Acadia Healthcar profitable?
No, Acadia Healthcar (ACHC) reported a net income of -$1.1B in fiscal year 2025, with a net profit margin of -33.3%.
How much debt does Acadia Healthcar have?
As of fiscal year 2025, Acadia Healthcar (ACHC) had $133.2M in cash and equivalents against $2.5B in long-term debt.
What is Acadia Healthcar's net profit margin?
Acadia Healthcar (ACHC) had a net profit margin of -33.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Acadia Healthcar's return on equity (ROE)?
Acadia Healthcar (ACHC) has a return on equity of -56.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Acadia Healthcar's free cash flow?
Acadia Healthcar (ACHC) generated -$439.9M in free cash flow during fiscal year 2025. This represents a 21.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Acadia Healthcar's operating cash flow?
Acadia Healthcar (ACHC) generated $131.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Acadia Healthcar's total assets?
Acadia Healthcar (ACHC) had $5.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Acadia Healthcar's capital expenditures?
Acadia Healthcar (ACHC) invested $571.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Acadia Healthcar's current ratio?
Acadia Healthcar (ACHC) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.
What is Acadia Healthcar's debt-to-equity ratio?
Acadia Healthcar (ACHC) had a debt-to-equity ratio of 1.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Acadia Healthcar's return on assets (ROA)?
Acadia Healthcar (ACHC) had a return on assets of -20.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Acadia Healthcar's Piotroski F-Score?
Acadia Healthcar (ACHC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Acadia Healthcar's earnings high quality?
Acadia Healthcar (ACHC) has an earnings quality ratio of -0.12x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Acadia Healthcar?
Acadia Healthcar (ACHC) scores 24 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.